436141-65-0 Usage
Uses
Used in Pharmaceutical Industry:
(3-CHLORO-4-METHYLSULFANYL-PHENYL)-ACETIC ACID METHYL ESTER is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to serve as a building block in the creation of new drugs with potential therapeutic applications.
Used in Research Applications:
In the field of research, (3-CHLORO-4-METHYLSULFANYL-PHENYL)-ACETIC ACID METHYL ESTER is utilized as a valuable tool for studying the interactions between organic molecules and biological systems. This understanding can lead to the development of new pharmaceuticals and a deeper comprehension of molecular interactions.
Used in Drug Development:
(3-CHLORO-4-METHYLSULFANYL-PHENYL)-ACETIC ACID METHYL ESTER is employed as a key component in the development of new drugs, particularly those with anti-inflammatory and analgesic properties. Its potential therapeutic effects make it a promising candidate for further investigation and application in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 436141-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,1,4 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 436141-65:
(8*4)+(7*3)+(6*6)+(5*1)+(4*4)+(3*1)+(2*6)+(1*5)=130
130 % 10 = 0
So 436141-65-0 is a valid CAS Registry Number.
436141-65-0Relevant articles and documents
5-SUBSTITUTED-PYRAZINE OR PYRIDINE GLUCOKINASE ACTIVATORS
-
Page 124, (2010/02/07)
The present invention provides a compound according to formula (I) where the substituent designations are provided in the specification. Pharmaceutical compositions comprising a compound according to formula (I) are also provided, said compounds being glucokinase activators which are useful in the treatment of type II diabetes.
Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
-
Page column 15-16, (2010/11/30)
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
Fused heteroaromatic glucokinase activators
-
, (2008/06/13)
Glucokinase activating amides are useful for increasing insulin secretion in the treatment of type II diabetes.